600645.SS
Price:
$22.24
Market Cap:
$10.12B
Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, primarily engages in the preparation and storage of cell tests in the People's Republic of China. The company provides cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental sub totipotent stem cells, immune cells, adipose stem cells, and dental stem cells. It also provides genetic testing services related to non-invasive prenatal genetic testing during pregnancy, safe medication guide gene testing for children and adults, disease genetic testing, disease susceptibility gene testing, etc.; and in vitro diagnostic raw materials, su...[Read more]
Industry
Biotechnology
IPO Date
1993-05-04
Stock Exchange
SHH
Ticker
600645.SS
According to Vcanbio Cell & Gene Engineering Corp., Ltd’s latest financial reports and current stock price. The company's current PE Ratio is 117.05. This represents a change of 283.84% compared to the average of 30.49 of the last 4 quarters.
The mean historical PE Ratio of Vcanbio Cell & Gene Engineering Corp., Ltd over the last ten years is 37.51. The current 117.05 PE Ratio has changed 31.10% with respect to the historical average. Over the past ten years (40 quarters), 600645.SS's PE Ratio was at its highest in in the March 2020 quarter at 463.75. The PE Ratio was at its lowest in in the September 2017 quarter at -527.84.
Average
37.51
Median
87.93
Minimum
-531.63
Maximum
268.00
Discovering the peaks and valleys of Vcanbio Cell & Gene Engineering Corp., Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 122.61%
Maximum Annual PE Ratio = 268.00
Minimum Annual Increase = -298.37%
Minimum Annual PE Ratio = -531.63
Year | PE Ratio | Change |
---|---|---|
2024 | 87.73 | -0.46% |
2023 | 88.13 | 25.10% |
2022 | 70.45 | -7.36% |
2021 | 76.04 | -205.18% |
2020 | -72.30 | -146.98% |
2019 | 153.91 | 34.54% |
2018 | 114.40 | -121.52% |
2017 | -531.63 | -298.37% |
2016 | 268.00 | 122.61% |
2015 | 120.39 | -70.28% |
The current PE Ratio of Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
82.10
5-year avg
50.01
10-year avg
37.51
Vcanbio Cell & Gene Engineering Corp., Ltd’s PE Ratio is greater than Zhejiang Daily Digital Culture Group Co.,Ltd. (32.43), greater than China Reform Culture Holdings Co., Ltd. (-8.55), greater than Shanghai Chlor-Alkali Chemical Co., Ltd. (13.82), greater than Harbin Pharmaceutical Group Co., Ltd. (14.97), greater than Aurora Optoelectronics Co.,Ltd. (-43.35),
Company | PE Ratio | Market cap |
---|---|---|
32.43 | $17.50B | |
-8.55 | $3.36B | |
13.82 | $8.95B | |
14.97 | $9.42B | |
-43.35 | $7.20B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vcanbio Cell & Gene Engineering Corp., Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vcanbio Cell & Gene Engineering Corp., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Vcanbio Cell & Gene Engineering Corp., Ltd's PE Ratio?
How is the PE Ratio calculated for Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS)?
What is the highest PE Ratio for Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS)?
What is the 3-year average PE Ratio for Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS)?
What is the 5-year average PE Ratio for Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS)?
How does the current PE Ratio for Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) compare to its historical average?